AstraZeneca and Zydus settle Nexium patent dispute

17-03-2017

AstraZeneca and Zydus settle Nexium patent dispute

stock_colors / iStockphoto.com

AstraZeneca and Zydus Pharmaceuticals have entered into a settlement agreement over a patent dispute centring on heartburn drug Nexium (esomeprazole).


AstraZeneca, Zydus, ANDA, FDA, settlement, patent, patent infringement, Nexium, heartburn

LSIPR